Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

The efficacy of olanzapine for decreasing cue-elicited craving in individuals with schizophrenia and cocaine dependence: a preliminary report.

Smelson DA, Ziedonis D, Williams J, Losonczy MF, Williams J, Steinberg ML, Kaune M.

J Clin Psychopharmacol. 2006 Feb;26(1):9-12.

PMID:
16415698
2.
3.

Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.

Lieberman JA, Tollefson G, Tohen M, Green AI, Gur RE, Kahn R, McEvoy J, Perkins D, Sharma T, Zipursky R, Wei H, Hamer RM; HGDH Study Group.

Am J Psychiatry. 2003 Aug;160(8):1396-404.

PMID:
12900300
4.

Olanzapine in cocaine dependence: a double-blind, placebo-controlled trial.

Hamilton JD, Nguyen QX, Gerber RM, Rubio NB.

Am J Addict. 2009 Jan-Feb;18(1):48-52. doi: 10.1080/10550490802544318.

PMID:
19219665
5.

Cocaine abuse in schizophrenic patients treated with olanzapine versus haloperidol.

Sayers SL, Campbell EC, Kondrich J, Mann SC, Cornish J, O'Brien C, Caroff SN.

J Nerv Ment Dis. 2005 Jun;193(6):379-86.

PMID:
15920378
6.

Aripiprazole in schizophrenia with cocaine dependence: a pilot study.

Beresford TP, Clapp L, Martin B, Wiberg JL, Alfers J, Beresford HF.

J Clin Psychopharmacol. 2005 Aug;25(4):363-6.

PMID:
16012280
7.

Risperidone decreases craving and relapses in individuals with schizophrenia and cocaine dependence.

Smelson DA, Losonczy MF, Davis CW, Kaune M, Williams J, Ziedonis D.

Can J Psychiatry. 2002 Sep;47(7):671-5.

PMID:
12355680
8.

Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, Chakos M, McEvoy JP.

J Clin Psychiatry. 2002 Oct;63(10):931-5.

PMID:
12416603
9.

Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.

Krakowski MI, Czobor P, Citrome L, Bark N, Cooper TB.

Arch Gen Psychiatry. 2006 Jun;63(6):622-9.

PMID:
16754835
10.

Olanzapine: an updated review of its use in the management of schizophrenia.

Bhana N, Foster RH, Olney R, Plosker GL.

Drugs. 2001;61(1):111-61. Review.

PMID:
11217867
11.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.

Tollefson GD, Beasley CM Jr, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.

Am J Psychiatry. 1997 Apr;154(4):457-65.

PMID:
9090331
12.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
13.
14.

Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approach.

Sauriol L, Laporta M, Edwardes MD, Deslandes M, Ricard N, Suissa S.

Clin Ther. 2001 Jun;23(6):942-56.

PMID:
11440294
15.

Effects of atypical antipsychotics on the syndromal profile in treatment-resistant schizophrenia.

Lindenmayer JP, Czobor P, Volavka J, Lieberman JA, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M.

J Clin Psychiatry. 2004 Apr;65(4):551-6.

PMID:
15119920
17.

A comparison of the efficacy and safety of olanzapine versus haloperidol during transition from intramuscular to oral therapy.

Wright P, Meehan K, Birkett M, Lindborg SR, Taylor CC, Morris P, Breier A.

Clin Ther. 2003 May;25(5):1420-8.

PMID:
12867218
18.

Antipsychotic medications for cocaine dependence.

Amato L, Minozzi S, Pani PP, Davoli M.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006306. Review. Update in: Cochrane Database Syst Rev. 2016;3:CD006306.

PMID:
17636840
19.
20.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241

Supplemental Content

Support Center